A Quality of Life and Safety Study With Pimecrolimus Cream, 1% in Children (Age 2-12 Years) With Atopic Dermatitis

Efficacy and Safety of Pimecrolimus Cream 1% in Patients (2 to 11 Years Old) With Mild to Moderate Facial Atopic Dermatitis

NCT00130364 ·Status: COMPLETED ·Phase: PHASE4

Comparison of Pimecrolimus Cream 1% Twice-Daily to Once-Daily Dosing in the Management of Atopic Dermatitis in Pediatric Subjects

NCT00139581 ·Status: COMPLETED ·Phase: PHASE4

Pimecrolimus Cream 1% Plus Topical Corticosteroid in Patients (2-17 Years of Age) With Severe Atopic Dermatitis

NCT00121381 ·Status: COMPLETED ·Phase: PHASE4

Open-label Study to Investigate Systemic Exposure in Adult and Pediatric Atopic Dermatitis Patients Treated 8.5 Days With Pimecrolimus Cream 1% Under Occlusion

NCT00925730 ·Status: COMPLETED ·Phase: PHASE4

Safety and Efficacy of Pimecrolimus Cream 1% in Mild to Moderate Head and Neck Atopic Dermatitis (AD) Patients

NCT00121316 ·Status: COMPLETED ·Phase: PHASE4

Study of Pimecrolimus Treatment for Atopic Dermatitis of African American Children

NCT00810862 ·Status: TERMINATED ·Phase: PHASE4

10 Year Registry of Children (Ages 2-17 Years) With Eczema That Have Used Pimecrolimus

NCT00568997 ·Status: ACTIVE_NOT_RECRUITING

Pimecrolimus Cream 1% in Patients (18 Years of Age and Over) With Mild to Moderate Chronic Hand Dermatitis

NCT00226707 ·Status: COMPLETED ·Phase: PHASE3

Open Label Study of Long Term Treatment of Pediatric Treatment of Atopic Dermatitis With Pimecrolimus Cream 1% Within a Usual Clinical Setting

NCT00509990 ·Status: COMPLETED ·Phase: PHASE4

Safety and Efficacy of Pimecrolimus Cream 1% in Atopic Disease Modification

NCT00124709 ·Status: TERMINATED ·Phase: PHASE4

A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Pediatric Atopic Dermatitis

NCT02748993 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Reconstitution With Pimecrolimus Cream 1% of Steroid-damaged Skin in Adults With Atopic Dermatitis

NCT00367393 ·Status: COMPLETED ·Phase: PHASE4

Safety Study of Roflumilast Cream 0.05% in Infants Aged 3 Months to Less Than 2 Years With Atopic Dermatitis

NCT06998056 ·Status: COMPLETED ·Phase: PHASE2

Tacrolimus Ointment Long Term Safety in Young Children With Atopic Dermatitis

NCT00560326 ·Status: COMPLETED ·Phase: PHASE2

Extension Study of Pimecrolimus Cream in Pediatric Patients With Atopic Dermatitis

NCT00231998 ·Status: COMPLETED ·Phase: PHASE3

Effects of Pimecrolimus Cream 1% on the Molecular and Cellular Profile of Adult Male Patients With Atopic Dermatitis

NCT00117377 ·Status: COMPLETED ·Phase: PHASE4

Effects of Pimecrolimus on Skin Biopsy Ex-plants From Patients With Atopic Dermatitis

NCT00379678 ·Status: COMPLETED

A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema

NCT06807268 ·Status: RECRUITING ·Phase: PHASE3

Short Term Growth in Children With Atopic Dermatitis

NCT00236106 ·Status: COMPLETED ·Phase: PHASE4

An Efficacy and Safety Study of Tacrolimus Ointment in Pediatric Participants With Atopic Dermatitis

NCT01782729 ·Status: COMPLETED ·Phase: PHASE4

Pimecrolimus and Epidermal Barrier Function

NCT01132079 ·Status: COMPLETED ·Phase: NA

Standardized Time- and Score-oriented Treatment of Moderate and Severe Atopic Dermatitis

NCT00148746 ·Status: COMPLETED ·Phase: NA

Comparison of the Efficacy and Safety of Two Topical Creams for Pediatric Atopic Dermatitis

NCT00828412 ·Status: COMPLETED ·Phase: PHASE4

A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema

NCT06807281 ·Status: RECRUITING ·Phase: PHASE3

Preventive Treatment of Tacrolimus Ointment in Children With Atopic Dermatitis

NCT01745159 ·Status: COMPLETED ·Phase: PHASE4